Megan Dwyer, MS, CGC, CGA-IGC Communications Committee member National Hereditary Cancer Week takes place from September 27 to October 3, with a focus on raising awareness of inherited cancer risk and promoting early detection through genetic testing and screening. A central part of this effort is cascade testing: testing family members after a cancer-related gene mutation is identified in a relative. Done well, it catches at-risk individuals before cancer develops, enabling

Hereditary Cancer Awareness Week begins September 27! CGA-IGC will mark the week with educational content, patient perspectives and practical resources for healthcare providers for their practice. From NCCN Guidelines updates and cascade testing to patient stories, infographics, specialist care resources and research collaborations, we’ll highlight opportunities to strengthen knowledge, support conversations and connect our community with care and research. A heartfelt thank

Jennifer Fijor, ARNP, CGA-IGC Communications Committee member The NCCN Guidelines for Genetic/Familial High-Risk Assessment were updated in June 2026, with real changes across colorectal, endometrial, gastric, and now esophageal cancer for the first time. Here's what changed, and where the field still doesn't agree: 1. Universal Lynch syndrome assessment expands, but it wasn't an easy vote Version 1.2026 now recommends universal Lynch syndrome assessment for all patients with

Ophir Gilad, MD - Communications Committee member If you missed our latest webinar, or would like to revisit the discussion, the full session is now available on-demand for CGA-IGC members. (Not yet a member? You can join here). This webinar featured Maegan E. Roberts, MS, CGC, Assistant Professor at The Ohio State University, who provided a practical guide to understanding variant summaries and reassessing assigned variant classifications. Ms. Roberts began by reviewing dif